Additionally, FADS2 knockdown enhanced the sensitivity of bladder cancer cells to FINs, suggesting that elevated FADS2 expression contributes to ferroptosis resistance in bladder cancer. This evidence concerns the gene FADS2 and urinary bladder cancer.